{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:42:49Z","timestamp":1781530969763,"version":"3.54.5"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3490,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.rmed.2003.09.003","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T16:01:18Z","timestamp":1067011278000},"page":"134-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Long-term montelukast therapy in moderate to severe COPD\u2014a preliminary observation"],"prefix":"10.1016","volume":"98","author":[{"given":"Israel","family":"Rubinstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schriever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2003.09.003_BIB1","unstructured":"National Heart, Lung and Blood Institute, World Health Organization. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO, Workshop Report, Publication No. 2701, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, MD, 2001."},{"key":"10.1016\/j.rmed.2003.09.003_BIB2","unstructured":"National Heart, Lung, and Blood Institute. Mortality and morbidity: 2000 chart book on cardiovascular, lung and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD, 2000."},{"key":"10.1016\/j.rmed.2003.09.003_BIB3","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2003.09.003_BIB4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrd820","article-title":"New treatments for COPD","volume":"1","author":"Barnes","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.rmed.2003.09.003_BIB5","first-page":"238","article-title":"Leukotrienes in respiratory disease","volume":"2","author":"McMillan","year":"2001","journal-title":"Paediatr Respir Rev"},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2003.09.003_BIB6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1081-1206(10)62305-8","article-title":"The Antileukotriene Working Group. Discovery of leukotrienes and development of antileukotriene agents","volume":"86","author":"Leff","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.rmed.2003.09.003_BIB7","first-page":"397","article-title":"Sputum leukotrienes in obstructive airways diseases","volume":"55","author":"O\u2019Driscoll","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rmed.2003.09.003_BIB8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0090-6980(87)90033-5","article-title":"The detection of 5-lipoxygenase and cyclooxygenase products in sputum of patients with chronic bronchitis and bronchiectasis","volume":"33","author":"Zakrzewski","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.rmed.2003.09.003_BIB9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/ajrccm\/136.3.779","article-title":"Lipid mediators in cystic fibrosis and chronic obstructive pulmonary disease","volume":"136","author":"Zakrzewski","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmed.2003.09.003_BIB10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0090-6980(87)90251-6","article-title":"Arachidonic acid metabolism in alveolar macrophages. A comparison of cells from healthy subjects, allergic asthmatics, and chronic bronchitis patients","volume":"34","author":"Damon","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.rmed.2003.09.003_BIB11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2001.112694","article-title":"Enhanced production of leukotrienes by peripheral leukocytes and specific IgE antibodies in patients with chronic obstructive pulmonary disease","volume":"107","author":"Mitsunobu","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2003.09.003_BIB12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1378\/chest.104.2.454","article-title":", Increased plasma levels of atrial natriuretic factor, rennin activity, and leukotriene C4 in chronic obstructive pulmonary disease","volume":"104","author":"Piperno","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2003.09.003_BIB13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0952-3278(97)90537-8","article-title":"Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease","volume":"56","author":"Shindo","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.rmed.2003.09.003_BIB14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/pupt.2000.0258","article-title":"Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT1-receptor antagonist","volume":"13","author":"Cazzola","year":"2000","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.rmed.2003.09.003_BIB15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000050550","article-title":"Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatment in asthma and chronic obstructive pulmonary disease","volume":"68","author":"Cazzola","year":"2001","journal-title":"Respiration"},{"key":"10.1016\/j.rmed.2003.09.003_BIB16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1378\/chest.122.1.289","article-title":"A randomized, placebo-controlled trial of a leukotriene synthesis inhibitor in patients with COPD","volume":"122","author":"Gompertz","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2003.09.003_BIB17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1046\/j.1440-1843.2002.00399.x","article-title":"Worldwide guidelines for chronic obstructive pulmonary disease","volume":"7","author":"Iqbal","year":"2002","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2003.09.003_BIB18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12019-996-0010-9","article-title":"Use of oral montelukast in the treatment of asthma","volume":"27","author":"Noonan","year":"2001","journal-title":"Compr Ther"},{"issue":"5 Suppl","key":"10.1016\/j.rmed.2003.09.003_BIB19","doi-asserted-by":"crossref","first-page":"197S","DOI":"10.1378\/chest.121.5_suppl.197S","article-title":"5-Lipoxygenase inhibitors for the treatment of COPD","volume":"121","author":"Kilfeather","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2003.09.003_BIB20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/thorax.56.3.244a","article-title":"Montelukast sodium in cystic fibrosis [letter]","volume":"56","author":"Morice","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2003.09.003_BIB21","unstructured":"American Thoracic Society. Standards for the diagnosis, care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77\u2013121."},{"key":"10.1016\/j.rmed.2003.09.003_BIB22","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1164\/ajrccm.160.6.9903136","article-title":"Reversal of human neutrophil survival by leukotriene B4 receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors","volume":"160","author":"Lee","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2003.09.003_BIB23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0952-3278(03)00070-X","article-title":"5-Lipoxygenase and FLAP","volume":"69","author":"Peters-Golden","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611103003093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611103003093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:05:51Z","timestamp":1760609151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611103003093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0954611103003093"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2003.09.003","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term montelukast therapy in moderate to severe COPD\u2014a preliminary observation","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2003.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}